Melanotan.org : afamelanotide, bremelanotide, and melanotan II info and forums.

General Information

Looking for the company that is developing Melanotan?

Try Clinuvel the company in Australia that is developing it.

Clinuvel Pharmaceuticals Limited is a sub-licencee of Melanotan from: Competitive Technologies
(Who originally licensed it from MelanoTan Corporation.)

Looking for the company that was developing a derivative of Melanotan II for erectile
dysfunction (ED) and female sexual dysfunction (FSD)?

Try http://www.palatin.com/ the company in New Jersey, USA that is now developing it for hemorrhagic shock.
Unfortunately for those looking on their site for the latest information concerning Melanotan II will find it mentioned only in the listing of publications regarding bremelanotide. This has greatly limited the ease with which interested parties can directly locate them via web searches relative to the term Melanotan II. Due to changes they've made to the Melanotan II peptide, they use the much less obvious name "bremelanotide". When surfing their site look for bremelanotide or pt-141 .

Palatin Technologies originally was a sub-licencee of Melanotan II from: Competitive Technologies. This original sub-license is no longer valid.

Melanotan.org Discussion Areas
Find discussions centered on the powder forms of these
peptides as well as the latest News/Info regarding
Melanotan (afamelanotide, formerly CUV1647), Melanotan II
and bremelanotide in our forums.

Publications about the Melanotan peptides

United States Patent Application for Melanocortin receptor agonists by Merck and Co (mentioning Melanotan)

Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II.
Wessells H, Levine N, Hadley ME, Dorr R, Hruby V.

Increased eumelanin expression and tanning is induced by a superpotent melanotropin [Nle4-D-Phe7]-alpha-MSH in humans.
Dorr RT, Dvorakova K, Brooks C, Lines R, Levine N, Schram K, Miketova P, Hruby V, Alberts DS.

Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study.
Wessells H, Fuciarelli K, Hansen J, Hadley ME, Hruby VJ, Dorr R, Levine N

Skin pigmentation and pharmacokinetics of melanotan-I in humans.
Ugwu SO, Blanchard J, Dorr RT, Levine N, Brooks C, Hadley ME, Aickin M, Hruby VJ.

Controlled-release delivery system for the alpha-MSH analog melanotan-I using poloxamer 407.
Bhardwaj R, Blanchard J.

Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study.
Dorr RT, Lines R, Levine N, Brooks C, Xiang L, Hruby VJ, Hadley ME.

Search the word Melanotan at the National Library of Medicine's PubMed site.

Melanotan-II Studied For Impotence of Psychological Origin Melanotan-II, a synthetic compound that influences skin pigmentation, has been shown to stimulate erections in men whose impotence has a psychological basis. (Journal of Urology 1998;160:389-393)

Dorr RT, Lines RR, Levine N, Brooks C, Xiang L, Hruby VJ, Hadley ME: Evaluation of Melanotan-II, A Superpotent Cyclic Melanotropic Peptide in a Pilot Phase-I Clinical Study, Life Sciences, Vol.58, No 20:1777-1784, 1996

N. Surendran, S.O. Uguw, L.D. Nguyen, E.J. Sterling, .T. Dorr and J. Blanchard, "Absorption Enhancement of Melanotan-I: Comparison of the Caco-2 and Rat In-Situ Models", Drug Delivery, 2, 49-55 (1995).

N. Surendran, L.D. Nguyen, A.R. Giuliano, and J. Blanchard, "Mechanisms of Acylcarnitine-mediated Enhancement of Calcium Transport in the Caco-2 Monolayer Model", J. PHarm. Sci., 84, 269-274 (1995).

N. Surendran, S.O. Ugwu, E.J. Sterling, and J. Blanchard, "High-performance Liquid Chromatographic Assay for Melanotan-1 in Biological Matrices", J. Chromatogr., 670, 235-242 (1995).

E.-L. Lan, S.O. Ugwu, J. Blanchard, X. Fang, V.J. Hruby and S. Sharma, "Preformulation Studies with Melanotan-II: A Potential Skin Cancer Chemopreventive Peptide", J. Pharm. Sci., 83, 1081-1084 (1994).

There are individuals who have experimented and are experimenting with these peptides individually. Melanotan.org discussion areas cover some of their experiments and experiences. Please note however that any experimentations done with these peptides are the sole responsibility of each individual practicing his or her own experiments and the operators/owners of Melanotan.org will not be held responsible for any and all use of information gathered from our sites in formulating said experiments.
USE INFORMATION CONTAINED IN THE DICUSSION AREAS AT YOUR OWN RISK.

This site in in no way affiliated with either Competitive Technologies, Palatin Technologies, or Clinuvel Pharmaceuticals Limited
or any of the sites linked to from this site.All linked to sites are solely responsible for the information they provide.
For questions concerning this site either utilize our discussion areas or send email
to the address found for the registrant of the domain Melanotan.com.

*** made on a MacBook Pro 17" *** khujgid7x5

A Jan. 21, 2009 New Zealand News report about the melanotan one "afamelanotide" bioabsorbable subcutaneous implant (not about melanotan II). Note: Melanotan.org is in no way affiliated with the Australian company Clinuvel Pharmaceuticals featured in this video. A related Wired Science article can be found here: Suntan Drug Greenlighted for Trials	Melanotan one "afamelanotide": Tan Without the Sun A September 8, 2004 Ivanhoe Broadcast News Production: From: HealthCentral.com
Australian "Today Tonight" article on this News	Note: The researchers in the image (from left to right) are Dermatologist Dr. Norman Levine, Endocrinologist Dr. Mac E. Hadley (1930-2006 - 1 2), and Pharmacologist Dr. Robert T. Dorr.